U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07300319) titled 'The Cancer Study: A Pilot Study' on Dec. 10. Brief Summary: The goal of this randomized co... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298239) titled 'An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell ... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298434) titled 'Study of VYD2311 for the Prevention of COVID-19' on Dec. 18. Brief Summary: The main purpo... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07299357) titled 'Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therap... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07299409) titled 'First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patien... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07300098) titled 'Epidemiological Evaluation of Knee Injuries in Children Admitted to Assiut University Hospi... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07300007) titled 'PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults' on Dec. 1... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298343) titled 'Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac ... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298096) titled 'A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess th... Read More
U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07299331) titled 'Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymp... Read More